ClinicalTrials.Veeva

Menu

Local Anesthetic as Single Shot Versus Catheter in Patients Undergoing Video Assisted Thoracoscopic Surgery

P

Poovendran Saththasivam

Status and phase

Terminated
Phase 2

Conditions

Thoracic Surgery

Treatments

Drug: Liposomal Bupivacaine (EXPAREL®)/Bupivacaine
Drug: Ropivacaine (0.5% bolus followed by 0.2% infusion)

Study type

Interventional

Funder types

Other

Identifiers

NCT04559347
2007-48

Details and patient eligibility

About

The purpose of this research is to compare a single shot long acting local anesthetic to catheter infusion of local anesthetic in patients undergoing video assisted thoracoscopic (VAT) surgery.

Full description

The purpose of this research is to compare Single Shot Liposomal Bupivacaine (EXPAREL®)/Bupivacaine (a long acting local anesthetic) to Ropivacaine (0.5% bolus followed by 0.2% infusion of local anesthetic using a catheter) in patients undergoing video assisted thoracoscopic (VAT) surgery.

Enrollment

45 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects who are age > 18, undergoing video thoracoscopic surgery and following Guthrie Robert Packer Hospital's Enhanced Recovery After Surgery (ERAS) protocol for Thoracic Surgery.

Exclusion criteria

  • weight < 50 kg, pregnant subjects,
  • left ventricular ejection fraction < 30%,
  • history of drug or narcotic abuse,
  • history of allergic to amide local anesthetic,
  • presence of contraindication for erector spinae plane block (local skin infection, sepsis, severe coagulopathy)
  • unable to provide consent,
  • unable to use pain rating scales as demonstrated by verbal feedback
  • preoperative chronic pain on narcotics,
  • history of renal insufficiency ( Creatinine > 1.5 mg/dl),
  • preoperative mild liver impairment ( i.e. AST/ALT above 1.5 times the upper normal limit)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 2 patient groups

Single Shot Liposomal Bupivacaine (EXPAREL®)/Bupivacaine
Experimental group
Description:
Single Shot Liposomal Bupivacaine (EXPAREL®)/Bupivacaine for erector spinae block as local anesthetic
Treatment:
Drug: Liposomal Bupivacaine (EXPAREL®)/Bupivacaine
Continuous catheter infusion ropivacaine
Active Comparator group
Description:
Ropivacaine (0.5% bolus followed by 0.2% infusion) using a continuous catheter for erector spinae plane block as local anesthetic
Treatment:
Drug: Ropivacaine (0.5% bolus followed by 0.2% infusion)

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Poovendran Saththasivam, MD; Nathaniel McElhaney, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems